Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 19, 2024 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025 Gimoti remains only approved drug shown to reduce hospitalizations, emergency room and medical...
August 18, 2022 09:30 ET | Source: CMI

Global Gastroparesis Treatment Market to Surpass US$ 10,726.0 Million by 2030, Says Coherent Market Insights (CMI)

Seattle, Aug. 18, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global gastroparesis treatment market is estimated to be valued at US$ 8,061.9 million in 2022 and expected to...
September 19, 2019 08:30 ET | Source: CinRx Pharma

CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102)

CINCINNATI, Sept. 19, 2019 (GLOBE NEWSWIRE) -- CinDome Pharma, Inc. (“CinDome”), a company whose lead product is deuterated domperidone (CIN-102), today announced that is has enrolled the first...
November 03, 2015 11:50 ET | Source: Neurogastrx

Neurogastrx Appoints Baxter Phillips III as President and Chief Executive Officer

CAMPBELL, Calif., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Neurogastrx, a biopharmaceutical company engaged in developing novel drugs for gastrointestinal disorders, today announced the appointment of...